BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27733853)

  • 1. The Role of Toll-Like Receptors in Hematopoietic Malignancies.
    Monlish DA; Bhatt ST; Schuettpelz LG
    Front Immunol; 2016; 7():390. PubMed ID: 27733853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.
    Paracatu LC; Schuettpelz LG
    Front Immunol; 2020; 11():1236. PubMed ID: 32625214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor signaling in hematopoietic stem and progenitor cells.
    Capitano ML
    Curr Opin Hematol; 2019 Jul; 26(4):207-213. PubMed ID: 31033704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
    Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
    Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor signaling in hematopoietic homeostasis and the pathogenesis of hematologic diseases.
    Cannova J; Breslin S J P; Zhang J
    Front Med; 2015 Sep; 9(3):288-303. PubMed ID: 26297301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.
    Wang JQ; Jeelall YS; Ferguson LL; Horikawa K
    Front Immunol; 2014; 5():367. PubMed ID: 25132836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toll-like receptors in development and function of the hematopoietic system].
    Vadillo E; Pelayo R
    Rev Invest Clin; 2012; 64(5):461-76. PubMed ID: 23544309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation].
    Majewska M; Szczepanik M
    Postepy Hig Med Dosw (Online); 2006; 60():52-63. PubMed ID: 16474276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.
    Yu L; Wang L; Chen S
    Biochim Biophys Acta; 2013 Apr; 1835(2):144-54. PubMed ID: 23232186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs).
    Franchini M; Zini E; Osto M; Jablonski K; Kaufmann K; Lutz TA; Reusch CE; Ackermann M
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):70-8. PubMed ID: 20674989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention.
    Zou H; Wang WK; Liu YL; Braddock M; Zheng MH; Huang DS
    Expert Opin Ther Targets; 2016 Sep; 20(9):1127-35. PubMed ID: 26998881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptors (TLRs): The Role in Tumor Progression.
    Shcheblyakov DV; Logunov DY; Tukhvatulin AI; Shmarov MM; Naroditsky BS; Gintsburg AL
    Acta Naturae; 2010 Jul; 2(3):21-9. PubMed ID: 22649649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages.
    Megías J; Yáñez A; Moriano S; O'Connor JE; Gozalbo D; Gil ML
    Stem Cells; 2012 Jul; 30(7):1486-95. PubMed ID: 22511319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation.
    Skert C; Fogli M; Garaffa E; Perucca S; Fiorentini S; Cancelli V; Turra A; Ribolla R; Filì C; Malagola M; Bergonzi C; Cattina F; Bernardi S; Caruso A; Di Palma A; Russo D
    Transpl Infect Dis; 2014 Oct; 16(5):697-712. PubMed ID: 25040166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.